May 28, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
KIAWAH ISLAND, S.C. — In patients with proliferative diabetic retinopathy, ranibizumab delivered with the Port Delivery System yielded a reduced need for rescue intervention vs. panretinal photocoagulation, according to a presenter. At Kiawah Eye and Retina, Ford Gordon, MD, highlighted a clinical gap in research for the Port Delivery System (Genentech, PDS) as a treatment for proliferative
May 28, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

KIAWAH ISLAND, S.C. — Several treatments are available across the landscape of proliferative diabetic retinopathy, each with…

Similar results in patients who had port delivery system for 4 years or switched after 64 weeks

LAS VEGAS — A VEGF/Ang-2 inhibitor demonstrated faster drying compared with faricimab in patients with diabetic macular edema,…

PHOENIX — A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years,…

DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual…

MONTREAL — In a phase 2b study, an intravitreal gene therapy reduced the treatment burden in patients with neovascular…